Diclofenac Epolamine

CHEMBL1201180 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
411.3 g/mol
LogP
Phase
4

The epolamine salt form of diclofenac used in transdermal patches for localized pain relief in acute minor musculoskeletal injuries. The topical route provides pain relief with lower systemic drug levels than oral formulations.

Peso Molecular

411,3000 g/mol

TPSA

72,80 Ų

Áreas Terapêuticas

Mecanismo de Ação

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl.OCCN1CCCC1

InChI

InChI=1S/C14H11Cl2NO2.C6H13NO/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19;8-6-5-7-3-1-2-4-7/h1-7,17H,8H2,(H,18,19);8H,1-6H2

Molecular Formula

C20H24Cl2N2O3

HBD / HBA

3 / 5

Ligações Rotacionáveis

6

Átomos Pesados

27

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

The epolamine salt form of diclofenac used in transdermal patches for localized pain relief in acute minor musculoskeletal injuries. The topical route provides pain relief with lower systemic drug levels than oral formulations.

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Yes, Diclofenac Epolamine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201180. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 114753. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.